Skip to main content
Midas Edge

PHIBRO ANIMAL HEALTH CORP

For the period ended Mar 31, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

PAHC$34.64+0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Changes in Stockholders’ Equity

​​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​
​ · ​ · Shares of · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Other · ​ · ​ · ​
​ · ​ · Common · ​ · Common · ​ · Preferred · ​ · Paid-in · ​ · Retained · ​ · Comprehensive · ​ · ​ · ​
​ · ​ ​ ​ · Stock · ​ ​ ​ · Stock · ​ ​ ​ · Stock · ​ ​ ​ · Capital · ​ ​ ​ · Earnings · ​ ​ ​ · Loss · ​ ​ ​ · Total
​ · ​ · (unaudited)
​ · ​ · (in thousands, except share and per share amounts)
As of June 30, 2025​ ​ ​40,533,608​$4​$—​$136,995​$272,701​$(124,018)​$285,682
Comprehensive income​—​​—​​—​​—​​26,527​​3,997​​30,524
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,864)​​—​​(4,864)
Stock-based compensation expense—​—​—​339​—​—​339
As of September 30, 2025​40,533,608​$4​$—​$137,334​$294,364​$(120,021)​$311,681
Comprehensive income (loss)​—​​—​​—​​—​​27,459​​(2,349)​​25,110
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,864)​​—​​(4,864)
Stock-based compensation expense​562​​—​​—​​434​​—​​—​​434
As of December 31, 202540,534,170​$4​$—​$137,768​$316,959​$(122,370)​$332,361
Comprehensive income​—​​—​​—​​—​​24,024​​9,899​​33,923
Shares issued pursuant to stock incentive plan​30,546​​—​​—​​—​​—​​—​​—
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,868)​​—​​(4,868)
Stock-based compensation expense​—​—​—​​411​​—​——​​411
As of March 31, 2026​40,564,716​$4​$—​$138,179​$336,115​$(112,471)​$361,827
​​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ ​ ​ · ​ · ​ ​ ​ · ​ · ​ · ​ · ​ · ​ · ​ ​ ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​
​ · ​ · Shares of · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Other · ​ · ​ · ​
​ · ​ · Common · ​ · Common · ​ · Preferred · ​ · Paid-in · ​ · Retained · ​ · Comprehensive · ​ · ​ · ​
​ · ​ ​ ​ · Stock · ​ ​ ​ · Stock · ​ ​ ​ · Stock · ​ ​ ​ · Capital · ​ ​ ​ · Earnings · ​ ​ ​ · Loss · ​ ​ ​ · Total
​ · ​ · (unaudited)
​ · ​ · (in thousands, except share and per share amounts)
As of June 30, 2024​40,503,608​$4​$—​$136,278​$243,886​$(123,527)​$256,641
Comprehensive income (loss)—​​—​​—​​—​​6,975​​(408)​6,567
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,860)​​—​​(4,860)
Stock-based compensation expense—​—​—​179​—​—​179
As of September 30, 2024​40,503,608​$4​$—​$136,457​$246,001​$(123,935)​$258,527
Comprehensive income (loss)​—​​—​​—​​—​​3,185​​(10,230)​​(7,045)
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,860)​​—​​(4,860)
Stock-based compensation expense​—​​—​​—​​180​​—​​—​180
As of December 31, 2024​40,503,608​$4​$—​$136,637​$244,326​$(134,165)​$246,802
Comprehensive income​—​​—​​—​​—​​20,880​​2,996​​23,876
Shares issued pursuant to stock incentive plan​30,000​​​​​​​​—​​—​​—​​—
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,865)​​—​​(4,865)
Stock-based compensation expense—​—​—​179​​—​​—​179
As of March 31, 202540,533,608​$4​$—​$136,816​$260,341​$(131,169)​$265,992

The accompanying notes are an integral part of these consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.